CN111407352A - An intelligent hemostatic device for bleeding during cesarean section - Google Patents
An intelligent hemostatic device for bleeding during cesarean section Download PDFInfo
- Publication number
- CN111407352A CN111407352A CN202010265186.9A CN202010265186A CN111407352A CN 111407352 A CN111407352 A CN 111407352A CN 202010265186 A CN202010265186 A CN 202010265186A CN 111407352 A CN111407352 A CN 111407352A
- Authority
- CN
- China
- Prior art keywords
- uterus
- pressing
- bag
- pressing bag
- hemostasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000740 bleeding effect Effects 0.000 title claims abstract description 17
- 230000002439 hemostatic effect Effects 0.000 title description 2
- 238000003825 pressing Methods 0.000 claims abstract description 67
- 210000004291 uterus Anatomy 0.000 claims abstract description 62
- 230000023597 hemostasis Effects 0.000 claims abstract description 33
- 238000005057 refrigeration Methods 0.000 claims abstract description 19
- 238000001816 cooling Methods 0.000 claims abstract description 9
- 239000008280 blood Substances 0.000 claims abstract description 8
- 210000004369 blood Anatomy 0.000 claims abstract description 8
- 210000003205 muscle Anatomy 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 49
- 239000000110 cooling liquid Substances 0.000 claims description 23
- 239000002775 capsule Substances 0.000 claims description 20
- 230000000694 effects Effects 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 210000004204 blood vessel Anatomy 0.000 claims description 9
- 210000003041 ligament Anatomy 0.000 claims description 5
- 210000003101 oviduct Anatomy 0.000 claims description 5
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000013013 elastic material Substances 0.000 claims description 2
- 230000003387 muscular Effects 0.000 claims description 2
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 2
- 239000004800 polyvinyl chloride Substances 0.000 claims description 2
- 239000000741 silica gel Substances 0.000 claims description 2
- 229910002027 silica gel Inorganic materials 0.000 claims description 2
- 241000446313 Lamella Species 0.000 claims 1
- 239000002826 coolant Substances 0.000 claims 1
- 238000010030 laminating Methods 0.000 claims 1
- 238000005192 partition Methods 0.000 claims 1
- 208000032843 Hemorrhage Diseases 0.000 abstract description 13
- 208000018525 Postpartum Hemorrhage Diseases 0.000 abstract description 10
- 230000006835 compression Effects 0.000 abstract description 8
- 238000007906 compression Methods 0.000 abstract description 8
- 238000011282 treatment Methods 0.000 abstract description 8
- 238000009802 hysterectomy Methods 0.000 abstract description 4
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 abstract 2
- 208000006083 Hypokinesia Diseases 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
- 230000017074 necrotic cell death Effects 0.000 abstract 1
- 230000000007 visual effect Effects 0.000 abstract 1
- 210000000685 uterine artery Anatomy 0.000 description 7
- 238000010586 diagram Methods 0.000 description 4
- 210000000754 myometrium Anatomy 0.000 description 4
- 208000010238 Uterine Inertia Diseases 0.000 description 3
- 206010046763 Uterine atony Diseases 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 239000000498 cooling water Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000010102 embolization Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 208000030016 Avascular necrosis Diseases 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 208000000091 Maternal Death Diseases 0.000 description 1
- 206010031264 Osteonecrosis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007894 caplet Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000012809 cooling fluid Substances 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 208000012285 hip pain Diseases 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/0053—Cabins, rooms, chairs or units for treatment with a hot or cold circulating fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B2017/12004—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord for haemostasis, for prevention of bleeding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0048—Genitals
- A61F2007/005—Genitals female
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0054—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water
- A61F2007/0056—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water for cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0054—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water
- A61F2007/0056—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water for cooling
- A61F2007/0057—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water for cooling of gas, e.g. air or carbon dioxide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种剖宫产术时出血智能化止血装置,属于外科器械技术领域。The invention relates to an intelligent hemostasis device for bleeding during cesarean section, belonging to the technical field of surgical instruments.
背景技术Background technique
我国的剖宫产率逐年上升,数据显示我国的剖宫产率高达46%,产后子宫收缩乏力十分常见,因此产后出血是剖宫产的常见并发症,产妇迅速的大量出血可引发失血性休克,严重者可危及产妇生命安全。产后出血是导致孕产妇死亡的四大原因之一,因此产后快速高效止血是临床治疗的关键措施。The cesarean section rate in my country is increasing year by year. Data shows that the cesarean section rate in my country is as high as 46%. Postpartum uterine atony is very common. Therefore, postpartum hemorrhage is a common complication of cesarean section. , in severe cases may endanger the safety of maternal life. Postpartum hemorrhage is one of the four major causes of maternal death, so rapid and efficient postpartum hemostasis is a key measure for clinical treatment.
当产妇发生宫缩乏力性产后出血时,当止血、输血,预防失血性休克等传统的保守治疗无效时,常选择手术止血。手术止血方式主要包括子宫切除术、子宫背带式缝合术、子宫动脉结扎术、双侧子宫动脉栓塞术及子宫填塞球囊导管等。子宫切除术对产后出血的治疗效果确实好,但会造成患者生殖器官以及生育能力的缺失,严重影响患者的心理健康和生活质量。子宫背带式缝合术主要是通过缝线压迫收缩乏力的子宫,从而使病患的子宫一直维持在收缩的状态,继而压迫病患的子宫动静脉,减少子宫出血,达到止血的效果,但是此方式属于有创手术,而且治疗后容易发生缝线滑脱或者子宫缺血坏死的问题。子宫动脉结扎术的手术操作较为复杂,且止血效果不佳,研究发现子宫动脉结扎术治疗产后出血的有效率仅为42%,且创伤较大,预后往往不佳。双侧子宫动脉栓塞术是在DSA指导下明确出血部位和出血范围,随后使用栓塞剂将子宫动脉进行阻断,本身操作复杂,而且会导致卵巢血供减少,可能导致卵巢功能发生障碍,术时部分患者出现臀部疼痛、发热等症状。虽然子宫填塞球囊导管治疗产后出血有一定的疗效,但是因为其作用力主要在宫腔表面,止血效果欠佳,也存在一定的产后子宫切除率和产后出血再发率,患者满意度不是很高。When puerperae suffer from postpartum hemorrhage due to uterine atony, when traditional conservative treatments such as hemostasis, blood transfusion, and prevention of hemorrhagic shock are ineffective, surgical hemostasis is often chosen. Surgical hemostasis mainly includes hysterectomy, uterine sling suture, uterine artery ligation, bilateral uterine artery embolization and uterine packing balloon catheter. Hysterectomy has a good effect on the treatment of postpartum hemorrhage, but it will cause the loss of reproductive organs and fertility of patients, which will seriously affect the mental health and quality of life of patients. Uterine sling suture mainly uses sutures to compress the atony uterus, so that the patient's uterus is maintained in a state of contraction, and then the patient's uterine arteries and veins are compressed to reduce uterine bleeding and achieve hemostasis. Effect, but this method It belongs to invasive surgery, and the problem of suture slippage or uterine avascular necrosis is easy to occur after treatment. The surgical operation of uterine artery ligation is relatively complicated, and the hemostasis effect is not good. Studies have found that the effective rate of uterine artery ligation in the treatment of postpartum hemorrhage is only 42%, and the trauma is relatively large, and the prognosis is often poor. Bilateral uterine artery embolization is to identify the bleeding site and scope of bleeding under the guidance of DSA, and then use an embolic agent to block the uterine artery. Some patients have symptoms such as hip pain and fever. Although the uterine tamponade balloon catheter has a certain curative effect in the treatment of postpartum hemorrhage, because its force is mainly on the surface of the uterine cavity, the hemostasis effect is not good, and there is a certain rate of postpartum hysterectomy and recurrence of postpartum hemorrhage, and patient satisfaction is not very high. high.
综上所述,面对剖腹产后出血问题,目前现有的治疗手段依旧存在创伤较大、副作用明显、效果不佳等问题。To sum up, facing the problem of bleeding after caesarean section, the existing treatment methods still have problems such as large trauma, obvious side effects, and poor effect.
发明内容SUMMARY OF THE INVENTION
本发明的目的是为了解决现有剖腹产术后出血,特别是临床产妇发生宫缩乏力性产后出血的问题,提供一种剖宫产术时出血智能化止血装置。该装置可以进行快速无创高效止血,止血方式无创伤、无副作用且止血效果佳。The purpose of the present invention is to provide an intelligent hemostasis device for bleeding during cesarean section in order to solve the existing bleeding after cesarean section, especially the problem of postpartum hemorrhage caused by uterine atony in clinical parturients. The device can perform fast, non-invasive and high-efficiency hemostasis, and the hemostasis method is non-invasive, has no side effects and has a good hemostatic effect.
本发明的目的是通过下述技术方案实现的。The purpose of the present invention is achieved through the following technical solutions.
一种剖宫产术时出血智能化止血装置,包括增压系统和按压囊;所述按压囊将子宫包覆其中;通过增压系统使得按压囊伸张贴合,给子宫造成压迫,促进肌层有力收缩,达到止血的目的。An intelligent hemostasis device for bleeding during cesarean section, comprising a pressurizing system and a pressing sac; the pressing sac wraps the uterus; the pressurizing sac is stretched and closed by the pressurizing system, causing compression to the uterus and promoting the muscular layer Strong contraction, to achieve the purpose of hemostasis.
所述按压囊为中空结构或非中空结构。The pressing capsule is a hollow structure or a non-hollow structure.
所述按压囊为中空结构时,增压系统通过气体或者液体实现增压。When the pressing bag is a hollow structure, the pressurizing system realizes pressurization through gas or liquid.
还包括用于给按压囊调节温度的制冷系统;通过控制气体或液体温度,子宫遇冷时肌层会有力收缩,从而实现剖宫产术时快速止血的目的。It also includes a refrigeration system for adjusting the temperature of the compression bag; by controlling the temperature of the gas or liquid, the muscle layer will contract forcefully when the uterus is cold, so as to achieve the purpose of rapid hemostasis during cesarean section.
同时控制循环的气体或液体的流量、流速以及温度,子宫在遇冷并且受压情况下血窦会快速闭合,促进子宫肌层有力收缩,从而实现高效,快速,无创,低温,智能化冷压迫子宫达到剖宫产术时快速止血的目的。At the same time, the flow rate, flow rate and temperature of the circulating gas or liquid are controlled. When the uterus is cold and compressed, the blood sinus will quickly close, which will promote the strong contraction of the myometrium, so as to achieve efficient, fast, non-invasive, low temperature, and intelligent cold compression. The uterus achieves the purpose of rapid hemostasis during cesarean section.
所述按压囊可以为单独的囊本体或者囊本体和调节环;The pressing bag can be a separate bag body or a bag body and an adjusting ring;
所述按压囊由囊本体和调节环;所述囊本体为分体结构;所述调节环用于使囊本体闭合;即将子宫置于囊本体中,再通过调节环使囊本体关闭,调节环上设置有多个不同孔位用来调节包覆子宫的初始位姿,所述按压囊外侧处调节环之间的间隙可供子宫两旁的血管、输卵管和韧带穿过。The pressing bag consists of a bag body and an adjusting ring; the bag body is a split structure; the adjusting ring is used to close the bag body; that is, the uterus is placed in the bag body, and then the bag body is closed by the adjusting ring, and the adjusting ring is used to close the bag body. A plurality of different holes are arranged on the uterus to adjust the initial posture of the uterus, and the space between the adjustment rings on the outside of the pressing bag can allow the blood vessels, fallopian tubes and ligaments on both sides of the uterus to pass through.
所述按压囊上设置有用于气体或液体的通行的入口和出口。An inlet and an outlet for the passage of gas or liquid are arranged on the pressing bag.
所述按压囊内部中空部分设置隔板,形成环形槽结构,该结构能够保证冷却液的流动面积,从而与子宫表面充分接触,达到快速冷却的目的。The inner hollow part of the pressing bag is provided with a baffle plate to form an annular groove structure, which can ensure the flow area of the cooling liquid, so as to fully contact the surface of the uterus and achieve the purpose of rapid cooling.
所述按压囊的外壳为仿生贝壳结构,既能起到放置子宫的作用,又能保证与子宫的最大接触面积,同时两瓣有凹度的按压囊片在压力达到一定数值后会尽力贴合,起到按压囊内子宫的作用;The shell of the pressing capsule is a bionic shell structure, which can not only play the role of placing the uterus, but also ensure the maximum contact area with the uterus. At the same time, the two concave pressing capsules will try their best to fit after the pressure reaches a certain value. , play the role of pressing the uterus in the capsule;
所述调节环上设置有多个不同孔位用来调节包覆子宫的初始位姿;所述按压囊外侧处调节环之间的间隙可供子宫两旁的血管、输卵管和韧带穿过,覆盖整个按压囊内部的环形槽可以保证冷却液的流动面积,从而与子宫表面充分接触,达到快速冷却的目的。The adjustment ring is provided with a plurality of different holes to adjust the initial posture of the uterus; the gap between the adjustment rings at the outside of the pressing bag can be used for the blood vessels, fallopian tubes and ligaments on both sides of the uterus to pass through, covering the entire uterus. Pressing the annular groove inside the bag can ensure the flow area of the cooling liquid, so as to fully contact the surface of the uterus and achieve the purpose of rapid cooling.
所述按压囊采用环保无毒的弹性材料,包括医用硅胶和聚氯乙烯。The pressing bag is made of environmentally friendly and non-toxic elastic materials, including medical silica gel and polyvinyl chloride.
所述提供制冷和增压功能的的制冷增压系统,由制冷机、水槽、水泵、系统报警指示灯和水位计组成;水槽的注水口负责向水槽内注入冷却液体,出水口与第二部分控制装置连接,回水口与按压囊的出水口相连,使得冷却液体得以循环流动,制冷机对水槽内液体进行制冷,水槽负责容纳冷却液体,水泵负责对冷却液体加压,系统报警指示灯用于监测整个系统是否正常运行,水位计用以监视水槽内冷却液体的存储量。The refrigeration pressurization system providing refrigeration and pressurization functions is composed of a refrigerator, a water tank, a water pump, a system alarm indicator and a water level gauge; the water injection port of the water tank is responsible for injecting cooling liquid into the water tank, and the water outlet is connected to the second part. The control device is connected, and the water return port is connected with the water outlet of the pressing bladder, so that the cooling liquid can circulate and flow, the refrigerator cools the liquid in the water tank, the water tank is responsible for containing the cooling liquid, and the water pump is responsible for pressurizing the cooling liquid. To monitor the normal operation of the entire system, the water level gauge is used to monitor the storage of cooling liquid in the water tank.
所述提供温控和调压功能的控制装置,主要由温控控制器和压力控制器组成;控制装置是连接制冷增压系统和按压囊的中间桥梁,温控控制器负责对温度进行调节和显示,压力控制器负责对压力进行调节和显示,通过控制装置为按压囊输送所需温度和压力的冷却液。The control device that provides temperature control and pressure regulation functions is mainly composed of a temperature control controller and a pressure controller; the control device is an intermediate bridge connecting the refrigeration booster system and the pressure bladder, and the temperature control controller is responsible for adjusting and adjusting the temperature. Display, the pressure controller is responsible for regulating and displaying the pressure, and delivering the cooling liquid of the required temperature and pressure to the pressing bladder through the control device.
采用所述装置器止血的方法,向水槽内注入适量的冷却液,制冷机和水泵对其进行制冷和加压,通过控制装置调节温度和压力至合适值,按压囊内安放待按压子宫,通过调节环进行初步固定;冷却液依次从水槽经出水口流进按压囊,流经整个环形槽之后返回制冷增压系统,以此循环反复;按压囊内部流经冷却液时,温度降低,同时两瓣按压囊片伸张贴合给子宫施加压力,在子宫遇冷并且受压的情况下血窦会快速闭合,血管快速收缩,促进子宫肌层有力收缩,从而实现高效,快速,无创,低温,智能化冷压迫子宫达到剖宫产术时快速止血的目的。Using the method of hemostasis with the device, an appropriate amount of cooling liquid is injected into the water tank, the refrigerator and the water pump are used to cool and pressurize it, the temperature and pressure are adjusted to appropriate values by the control device, and the uterus to be pressed is placed in the pressing capsule, and the The adjusting ring is preliminarily fixed; the cooling liquid flows from the water tank through the water outlet into the pressing bag in turn, flows through the entire annular groove and then returns to the refrigeration booster system, and the cycle repeats; when the cooling liquid flows through the pressing bag, the temperature decreases, and the two The valve presses the caplet to apply pressure to the uterus. When the uterus is cold and compressed, the blood sinus will quickly close, the blood vessels will contract rapidly, and the myometrium will be contracted forcefully, so as to achieve high efficiency, fast, non-invasive, low temperature, intelligent The purpose of rapid hemostasis during cesarean section is achieved by compressing the uterus with cold.
有益效果:Beneficial effects:
1、本发明公开的一种剖宫产术时出血智能化止血装置,通过制冷增压系统和控制装置为按压囊提供所需温度和压力的冷却液,控制装置分别装有温控控制器和压力控制器,用以读取调节温度和压力,制冷增压系统的出水口和回水口可以实现冷却液以恒定温度循环使用,冷却效果更佳。1. A kind of intelligent hemostasis device for bleeding during cesarean section disclosed by the present invention provides cooling liquid of required temperature and pressure for the pressing bag through a refrigeration booster system and a control device, and the control device is respectively equipped with a temperature control controller and a control device. The pressure controller is used to read and adjust the temperature and pressure. The water outlet and return port of the refrigeration booster system can realize the circulation of the cooling liquid at a constant temperature, and the cooling effect is better.
2、本发明公开的一种剖宫产术时出血智能化止血装置,按压囊形状仿生贝壳,既能起到放置子宫的作用,又能保证最大接触面积,同时两瓣有凹度的按压囊片在压力达到一定数值后会尽力贴合,达到按压囊内子宫的目的,均匀分布在按压囊周围的调节环上的不同孔位用来调节包覆子宫的初始位姿,按压囊外侧处调节环之间的间隙可供子宫两旁的血管、输卵管和韧带穿过,覆盖整个按压囊内部的环形槽可以保证冷却液的流动面积,从而与子宫表面充分接触,使得子宫遇冷并且受压,血窦快速闭合,血管快速收缩,促进子宫肌层有力收缩,从而实现高效,快速,无创,低温,智能化冷压迫子宫达到剖宫产术时快速止血的目的。2. The invention discloses an intelligent hemostasis device for bleeding during cesarean section, which can press the bionic shell in the shape of the capsule, which can not only play the role of placing the uterus, but also ensure the maximum contact area. At the same time, the two flaps have a concave pressing capsule After the pressure reaches a certain value, the tablet will try its best to fit to achieve the purpose of pressing the uterus in the capsule. The different holes on the adjustment ring evenly distributed around the pressing capsule are used to adjust the initial posture of the uterus, and the outer side of the pressing capsule is adjusted. The gap between the rings can allow the blood vessels, fallopian tubes and ligaments on both sides of the uterus to pass through, and the annular groove covering the entire interior of the compression bag can ensure the flow area of the cooling fluid, so as to fully contact the surface of the uterus, so that the uterus is cold and compressed, and blood The sinus is quickly closed, the blood vessels are rapidly contracted, and the myometrium is strongly contracted, so as to achieve efficient, rapid, non-invasive, low temperature, and intelligent cold compression of the uterus to achieve the purpose of rapid hemostasis during cesarean section.
3、本发明公开的一种剖宫产术时出血智能化止血装置,一共分为三个部分,各个部分功能明确,便于移动和安放,适用于临床使用。3. The intelligent hemostasis device for bleeding during cesarean section disclosed in the present invention is divided into three parts, each part has clear functions, is convenient for movement and placement, and is suitable for clinical use.
附图说明Description of drawings
图1是本发明制冷增压系统结构图;Fig. 1 is the structure diagram of the refrigeration booster system of the present invention;
图2是本发明的控制装置结构图;Fig. 2 is the structure diagram of the control device of the present invention;
图3是本发明的按压囊外形结构图;Fig. 3 is the outline structure diagram of the pressing bag of the present invention;
图4是本发明的按压囊内部结构图。FIG. 4 is an internal structure diagram of the compression bag of the present invention.
1-制冷增压系统、2-控制装置、3-按压囊、4-调节环、5-入水口、6-出水口、7-环形槽。1-Refrigeration booster system, 2-Control device, 3-Pressing bladder, 4-Adjusting ring, 5-Water inlet, 6-Water outlet, 7-Annular groove.
具体实施方式Detailed ways
以下结合附图和实施实例对本发明进一步说明。The present invention will be further described below with reference to the accompanying drawings and implementation examples.
实施例1Example 1
参见附图1所示,本发明所述的一种剖宫产术时出血智能化止血装置的制冷增压系统1主要包括注水口、回水口、出水口、制冷机、水槽、水泵、系统报警指示灯和水位计组成;注水口负责向水槽内注入冷却液体,出水口与第二部分控制装置2连接,回水口与按压囊3的出水口6相连,使得冷却液体得以循环流动,制冷机对水槽内液体进行制冷,水槽负责容纳冷却液体,水泵负责对冷却液体加压,系统报警指示灯用于监测整个系统是否正常运行,水位计用以监视水槽内冷却液体的存储量。Referring to Figure 1, a refrigeration booster system 1 of an intelligent hemostasis device for bleeding during cesarean section according to the present invention mainly includes a water injection port, a water return port, a water outlet, a refrigerator, a water tank, a water pump, and a system alarm. It consists of an indicator light and a water level gauge; the water injection port is responsible for injecting cooling liquid into the water tank, the water outlet is connected to the second part of the
参见附图2所示,本发明所述的控制装置2由温控控制器和压力控制器组成;控制装置是连接制冷增压系统1和按压囊3的中间桥梁,温控控制器负责对温度进行调节和显示,压力控制器负责对压力进行调节和显示,通过控制装置为按压囊3输送所需温度和压力的冷却液。Referring to Fig. 2, the
参见附图3和附图4所示,本发明所述的按压囊3由调节环4、环形槽7、入水口5、出水口6组成;按压囊3形状仿生贝壳,既能起到放置子宫的作用,又能保证最大接触面积,同时两瓣有凹度的按压囊片在压力达到一定数值后会尽力贴合,起到按压囊内子宫的作用,调节环4上的不同孔位用来调节包覆子宫的初始位姿,按压囊外侧处的缺口可供子宫两旁的血管、输卵管和韧带穿过,覆盖整个按压囊内部的环形槽7可以保证冷却液的流动面积,从而与子宫表面充分接触,达到快速冷却的目的,入水口5通过控制装置与制冷增压系统1的出水口相连,出水口6与制冷增压系统1的回水口相连,这样可以保证冷却夜通过循环流动保持恒定的低温,冷却效果更佳。Referring to Figures 3 and 4, the
本实施例公开的一种剖宫产术时出血智能化止血装置的工作方法为:向冷水机内注入适量的水,冷却水出口通过增压泵装置与按压囊相连,按压囊内安放待按压子宫,通过调节环进行固定。待冷却机内的水冷却到合适温度时,调节增压泵至所需压力值,冷却水依次流进按压囊,流经整个环形槽之后返回冷水机,以此循环反复。按压囊内部流经冷却水时,温度降低,伸张贴合给子宫施加压力,子宫遇冷并且受压,血窦快速闭合,血管快速收缩,促进子宫肌层有力收缩,从而实现高效,快速,无创,低温,智能化冷压迫子宫达到剖宫产术时快速止血的目的。The working method of an intelligent hemostasis device for bleeding during cesarean section disclosed in this embodiment is as follows: inject an appropriate amount of water into the chiller, the cooling water outlet is connected to the pressing bag through the booster pump device, and the pressing bag is placed to be pressed. The uterus is fixed by an adjustment ring. When the water in the cooler is cooled to an appropriate temperature, adjust the booster pump to the required pressure value, and the cooling water flows into the pressing bag in turn, flows through the entire annular groove, and then returns to the chiller, and the cycle repeats. When the cooling water flows through the inside of the pressing bag, the temperature decreases, and the stretched fitting puts pressure on the uterus. When the uterus is cold and compressed, the blood sinuses are quickly closed, the blood vessels are rapidly contracted, and the myometrium is strongly contracted, so as to achieve high efficiency, rapidity and non-invasiveness. , Low temperature, intelligent cold compression of the uterus to achieve rapid hemostasis during cesarean section.
实施例2Example 2
结构采用增压装置和非中空按压囊,工作方法为:将子宫放在按压囊内,增压装置可采用机械臂,通过增压装置压迫囊内子宫,即采用机械装置模仿人类手工按压方式,促进血管收缩,达到快速止血的目的。The structure adopts a pressurizing device and a non-hollow pressing bag. The working method is as follows: put the uterus in the pressing bag, and the pressurizing device can use a mechanical arm to press the uterus in the bag through the pressurizing device, that is, a mechanical device is used to imitate the manual pressing method of human beings. Promote vasoconstriction and achieve rapid hemostasis.
实施例3Example 3
结构为制冷系统和非中空的按压囊,工作方法为将子宫置入按压囊内,通过制冷系统对囊内子宫进行降温处理,达到止血的目的。The structure is a refrigeration system and a non-hollow pressing bag, and the working method is that the uterus is placed in the pressing bag, and the uterus in the bag is cooled by the refrigeration system to achieve the purpose of hemostasis.
实施例4Example 4
结构和工作方法类似实施例1,区别在于将液体改为气体。The structure and working method are similar to those of Example 1, except that the liquid is changed to gas.
虽然上述操作方法都对止血有一定的效果,但是冷却和按压同步进行要比单独进行止血效果更好,虽然可以将介质采用气体,但是气体遇冷会凝结,所以相对来说会有一定的局限性。Although the above operation methods have a certain effect on hemostasis, simultaneous cooling and pressing are more effective than separate hemostasis. Although gas can be used as the medium, the gas will condense when it is cold, so there will be certain limitations. sex.
以上所述的具体描述,对发明的目的、技术方案和有益效果进行了进一步详细说明,所应理解的是,以上所述仅为本发明的具体实施例而已,并不用于限定本发明的保护范围,凡在本发明的精神和原则之内,所做的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The above-mentioned specific descriptions further describe the purpose, technical solutions and beneficial effects of the present invention in detail. It should be understood that the above-mentioned descriptions are only specific embodiments of the present invention, and are not intended to limit the protection of the present invention. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included within the protection scope of the present invention.
Claims (10)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010191164 | 2020-03-18 | ||
| CN2020101911642 | 2020-03-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111407352A true CN111407352A (en) | 2020-07-14 |
Family
ID=71485438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010265186.9A Pending CN111407352A (en) | 2020-03-18 | 2020-04-07 | An intelligent hemostatic device for bleeding during cesarean section |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111407352A (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2410047C1 (en) * | 2009-11-09 | 2011-01-27 | Общество с ограниченной ответственностью "ГинаМед" | Method of uterine postpartum haemorrhage treatment and double balloon catheter for its implementation |
| CN202859208U (en) * | 2012-10-24 | 2013-04-10 | 杨筱青 | Air bag bolt for cervix uteri blood stopping |
| WO2014199347A1 (en) * | 2013-06-13 | 2014-12-18 | Cotterall-Lagana Teresa | Intra-operative pressure cuff to reduce organ bleeding |
| WO2015044197A1 (en) * | 2013-09-24 | 2015-04-02 | Georg-Albrecht Meyer | Device for use for the therapy of uterine bleeding |
| CN204318828U (en) * | 2014-11-28 | 2015-05-13 | 湖州市妇幼保健院 | A kind of for Celiotomy Wean compression hemostasis water sag |
| CN206228391U (en) * | 2016-06-27 | 2017-06-09 | 首都医科大学附属北京世纪坛医院 | A kind of intelligent radial artery compression hemostatic device |
| CN207101323U (en) * | 2017-02-07 | 2018-03-16 | 杨敬芹 | A kind of in utero hemostasis device for gynemetrics |
| CN209315962U (en) * | 2018-09-19 | 2019-08-30 | 师伟 | A kind of uterine cavity local hemostasis device for abnormal uterine bleeding |
| CN212650869U (en) * | 2020-03-18 | 2021-03-05 | 朱玉梅 | Intelligent hemostasis device for bleeding during cesarean section |
-
2020
- 2020-04-07 CN CN202010265186.9A patent/CN111407352A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2410047C1 (en) * | 2009-11-09 | 2011-01-27 | Общество с ограниченной ответственностью "ГинаМед" | Method of uterine postpartum haemorrhage treatment and double balloon catheter for its implementation |
| CN202859208U (en) * | 2012-10-24 | 2013-04-10 | 杨筱青 | Air bag bolt for cervix uteri blood stopping |
| WO2014199347A1 (en) * | 2013-06-13 | 2014-12-18 | Cotterall-Lagana Teresa | Intra-operative pressure cuff to reduce organ bleeding |
| WO2015044197A1 (en) * | 2013-09-24 | 2015-04-02 | Georg-Albrecht Meyer | Device for use for the therapy of uterine bleeding |
| CN204318828U (en) * | 2014-11-28 | 2015-05-13 | 湖州市妇幼保健院 | A kind of for Celiotomy Wean compression hemostasis water sag |
| CN206228391U (en) * | 2016-06-27 | 2017-06-09 | 首都医科大学附属北京世纪坛医院 | A kind of intelligent radial artery compression hemostatic device |
| CN207101323U (en) * | 2017-02-07 | 2018-03-16 | 杨敬芹 | A kind of in utero hemostasis device for gynemetrics |
| CN209315962U (en) * | 2018-09-19 | 2019-08-30 | 师伟 | A kind of uterine cavity local hemostasis device for abnormal uterine bleeding |
| CN212650869U (en) * | 2020-03-18 | 2021-03-05 | 朱玉梅 | Intelligent hemostasis device for bleeding during cesarean section |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5716386A (en) | Non-invasive aortic impingement and core and cerebral temperature manipulation | |
| US5531776A (en) | Non-invasive aortic impingement and core and cerebral temperature manipulation method | |
| US3924628A (en) | Cyrogenic bladder for necrosing tissue cells | |
| US7625368B2 (en) | Endometrial ablation device and method | |
| US9402676B2 (en) | Cryoablation balloon catheter and related method | |
| US8323324B2 (en) | Therapeutic heating and cooling via temperature management of a colon-inserted dual balloon | |
| EP0672400B1 (en) | Cooling cylindrical device for therapeutic treatment of hemorrhoids | |
| US20020016608A1 (en) | Non-invasive aortic impingement | |
| Vilos et al. | Endometrial ablation with a thermal balloon for the treatment of menorrhagia | |
| US20200038237A1 (en) | Gastric, cutaneous, or peritoneal delivery of frozen mist to induce therapeutic hyperthermia | |
| Chen et al. | Direct puncture embolization of the internal iliac artery during cesarean delivery for pernicious placenta previa coexisting with placenta accreta | |
| Phillips et al. | Traditional uterine tamponade and vacuum-induced uterine tamponade devices in obstetrical hemorrhage management | |
| Vilos et al. | Endometrial thermal balloon ablation with the ThermaChoice system: effect of intrauterine pressure and duration of treatment | |
| CN212650869U (en) | Intelligent hemostasis device for bleeding during cesarean section | |
| CN212699012U (en) | High-efficient hemostasis device that interior outer bag combines | |
| CN111493963A (en) | A high-efficiency hemostatic device combining internal and external capsules | |
| CN111407352A (en) | An intelligent hemostatic device for bleeding during cesarean section | |
| CN113456157A (en) | Clinical hemostasis by pressing device for intracardiac branch of academic or vocational study | |
| CN211213813U (en) | Continuous cold compress device for obstetrics and gynecology department | |
| DINGMAN et al. | Congenital arteriovenous fistulae of the external ear | |
| Miller et al. | Non-pneumatic anti-shock garment | |
| CN219332183U (en) | Circulation cold compress device | |
| Gharoro et al. | Prophylactic internal iliac artery ligation in gynecologic pelvic surgery | |
| CN221830710U (en) | An emergency hemostasis device | |
| CN215960086U (en) | Be used for quick hemostasis device of gynaecology and obstetrics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200714 |